beta-lactamase-IN-1;4-(1,3-Dihydroxypropan-2-Yl)-6-Methoxypyrido[2,3-B]Pyrazin-3(4H)-One;4-(1,3-Dihydroxypropan-2-Yl)-6-Methoxypyrido[2,3-B]Pyrazin-3(4H)-One(WXC01738);beta-lactamase inhibitor 1;β-Lactamase-IN-1;Pyrido[2,3-b]pyrazin-3(4H)-one, 4-[2-hydroxy-1-(hydroxymethyl)ethyl]-6-methoxy-;β-Lactamase-IN-1, 10 mM in DMSO
Treating Neisseria gonorrhoeae infection which comprises administering to a subject in need thereof novel Tricyclic nitrogen containing compounds and corresponding pharmaceutical compositions as described herein.
